Phylogeny-Guided Approach Yields Glycopeptides with Unique Action

Area of Science:

• Microbiology
• Genomics
• Drug Discovery

Background:

• Bacteria develop resistance to existing antibiotics through diverse mechanisms.
• The urgent need for novel antibiotics with new targets drives scientific research.
• Glycopeptides are a class of antibiotics, but resistance is a growing concern.

Purpose of the Study:

• To identify novel glycopeptides with unique mechanisms of action.
• To explore Actinomycetes genomes for new antibiotic compounds.
• To address the challenge of increasing antibiotic resistance.

Main Methods:

• Utilized a phylogeny-guided approach to screen Actinomycetes genomes.
• Focused on identifying glycopeptide antibiotics.
• Analyzed genomic data to find compounds with potentially novel targets.

Main Results:

• Identified two new glycopeptides: complestatin and corbomycin.
• These antibiotics exhibit different molecular targets compared to previously known glycopeptides.
• The findings highlight the potential of genomic mining for antibiotic discovery.

Conclusions:

• Complestatin and corbomycin represent promising candidates for new antibacterial therapies.
• Genomic approaches are effective in discovering antibiotics with novel mechanisms.
• Further research is warranted to explore the therapeutic potential of these compounds.